Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03312556
NA

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension. The purpose of this study is to assess whether continuous positive airway pressure (CPAP) decreases blood pressure in autonomic failure patients with supine hypertension.

Official title: Treatment of Supine Hypertension in Autonomic Failure With Continuous Positive Airway Pressure

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2017-09-21

Completion Date

2026-12-21

Last Updated

2025-11-06

Healthy Volunteers

No

Interventions

DEVICE

continuous positive airway pressure (CPAP)

Continuous positive airway pressure(CPAP) will be applied during the night starting from 20:00. CPAP level will be determined during an acute CPAP trial.

DRUG

Placebo

Placebo pill or patch. Single dose

Locations (1)

Autonomic Dysfunction Center/ Vanderbilt University Medical Center

Nashville, Tennessee, United States